Skip to main content

Novartis

 

Clinical courses

 

Clinical research courses

  • Opening for M.Pharm, M.Sc as Pharma Facilities Manager @ Novartis

    A global healthcare leader, Novartis has one of the most exciting product pipelines in the industry today. A pipeline of innovative medicines brought to life by diverse, talented and performance driven people. All of which makes them one of the most rewarding employers in their field.

    Post: Pharma Facilities Manager

  • Job for Senior Manager QA- Global Dev QA @ Novartis

    A global healthcare leader, Novartis has one of the most exciting product pipelines in the industry today. A pipeline of innovative medicines brought to life by diverse, talented and performance driven people. All of which makes them one of the most rewarding employers in their field.

    Post: Sr Mgr QA-Global Dev QA

  • Opening for post of Manager-Database Operations @ Novartis

    A global healthcare leader, Novartis has one of the most exciting product pipelines in the industry today. A pipeline of innovative medicines brought to life by diverse, talented and performance driven people. All of which makes them one of the most rewarding employers in their field.

    Post: Manager-Database Operations

  • Vacancy as Pharmaceutical Scientist II @ Novartis

    A global healthcare leader, Novartis has one of the most exciting product pipelines in the industry today. A pipeline of innovative medicines brought to life by diverse, talented and performance driven people. All of which makes them one of the most rewarding employers in their field.

    Post: Pharmaceutical Scientist II

  • Career to work as Cell Lead in Novartis | M.Pharm, M.Sc

    A global healthcare leader, Novartis has one of the most exciting product pipelines in the industry today. A pipeline of innovative medicines brought to life by diverse, talented and performance driven people. All of which makes them one of the most rewarding employers in their field.

    Post: Cell Lead

  • Career Opportunity for M.Pharm, Ph.D as Senior Pharmaceutical Scientist II @ Novartis

    A global healthcare leader, Novartis has one of the most exciting product pipelines in the industry today. A pipeline of innovative medicines brought to life by diverse, talented and performance driven people. All of which makes them one of the most rewarding employers in their field.

    Post: Senior Pharmaceutical Scientist II

  • Recruitment for Principal Pharma Scientist @ Novartis

    A global healthcare leader, Novartis has one of the most exciting product pipelines in the industry today. A pipeline of innovative medicines brought to life by diverse, talented and performance driven people. All of which makes them one of the most rewarding employers in their field.

    Post: Principal Pharma Scientist

  • Opening for Graduation in Pharmacy as Medical Sales Representative in Novartis

    A global healthcare leader, Novartis has one of the most exciting product pipelines in the industry today. A pipeline of innovative medicines brought to life by diverse, talented and performance driven people. All of which makes them one of the most rewarding employers in their field.

    Post: Medical Sales Representative

  • Opening to work as Senior Scientific Writer 2 in Novartis | Require M.Sc/M.Pharm

    A global healthcare leader, Novartis has one of the most exciting product pipelines in the industry today. A pipeline of innovative medicines brought to life by diverse, talented and performance driven people. All of which makes them one of the most rewarding employers in their field.

    Post: Senior Scientific Writer 2

  • Novartis's Jakavi ® shows positive Phase III results in Polycythemia Vera

    Novartis announced that Jakavi ® (ruxolitinib) showed positive reponse in compare to present therpies for Polycythemia Vera, a rare and incurable blood cancer with increase number of erythrocytes production. In phase III trial, Jakavi ® succeed to maintain hematocrit control, erythrocytes volume, without the need of phlebotomy and reducing spleen size in patients with polycythemia vera resistant to or intolerant of hydroxyurea.

Subscribe to Novartis